 Marta Ceko
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibromyalgia | 8 | 2021 | 55 | 2.020 |
Why?
| | Chronic Pain | 10 | 2023 | 208 | 2.010 |
Why?
| | Cerebral Cortex | 5 | 2020 | 380 | 1.420 |
Why?
| | Pain | 6 | 2022 | 701 | 1.060 |
Why?
| | Brain Mapping | 6 | 2022 | 521 | 0.980 |
Why?
| | Brain | 6 | 2023 | 2355 | 0.900 |
Why?
| | Pain Measurement | 5 | 2021 | 441 | 0.770 |
Why?
| | Cognition | 4 | 2018 | 990 | 0.760 |
Why?
| | Magnetic Resonance Imaging | 13 | 2022 | 3039 | 0.710 |
Why?
| | Connectome | 2 | 2021 | 63 | 0.690 |
Why?
| | Healthy Volunteers | 3 | 2020 | 191 | 0.650 |
Why?
| | Neural Pathways | 5 | 2021 | 260 | 0.560 |
Why?
| | Memory, Short-Term | 2 | 2016 | 227 | 0.530 |
Why?
| | Low Back Pain | 2 | 2021 | 93 | 0.470 |
Why?
| | Memory Disorders | 1 | 2015 | 153 | 0.460 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 160 | 0.460 |
Why?
| | Nociception | 1 | 2014 | 17 | 0.450 |
Why?
| | Nerve Net | 2 | 2021 | 227 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 63 | 0.440 |
Why?
| | Benzamides | 1 | 2014 | 168 | 0.430 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 94 | 0.430 |
Why?
| | Cold Temperature | 1 | 2014 | 125 | 0.430 |
Why?
| | Polyradiculopathy | 1 | 2012 | 3 | 0.410 |
Why?
| | Hot Temperature | 1 | 2014 | 301 | 0.400 |
Why?
| | Nerve Fibers | 1 | 2012 | 86 | 0.390 |
Why?
| | Piperazines | 1 | 2014 | 310 | 0.380 |
Why?
| | Pyrimidines | 1 | 2014 | 374 | 0.370 |
Why?
| | Analgesia | 2 | 2021 | 82 | 0.330 |
Why?
| | Pain Threshold | 3 | 2014 | 67 | 0.320 |
Why?
| | Emotions | 3 | 2021 | 474 | 0.320 |
Why?
| | Pain Perception | 4 | 2014 | 37 | 0.260 |
Why?
| | Touch | 2 | 2016 | 30 | 0.240 |
Why?
| | Prefrontal Cortex | 2 | 2018 | 263 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1875 | 0.210 |
Why?
| | Placebo Effect | 2 | 2021 | 52 | 0.210 |
Why?
| | Middle Aged | 10 | 2020 | 26605 | 0.210 |
Why?
| | Adult | 13 | 2021 | 30375 | 0.200 |
Why?
| | Affect | 2 | 2022 | 246 | 0.190 |
Why?
| | Hypothalamus, Posterior | 1 | 2021 | 4 | 0.190 |
Why?
| | Periaqueductal Gray | 1 | 2021 | 15 | 0.190 |
Why?
| | Humans | 24 | 2023 | 114045 | 0.190 |
Why?
| | Pulvinar | 1 | 2021 | 4 | 0.190 |
Why?
| | Escape Reaction | 1 | 2021 | 58 | 0.190 |
Why?
| | Superior Colliculi | 1 | 2021 | 33 | 0.180 |
Why?
| | Functional Neuroimaging | 1 | 2021 | 71 | 0.180 |
Why?
| | Deception | 1 | 2020 | 16 | 0.170 |
Why?
| | Female | 16 | 2021 | 59324 | 0.170 |
Why?
| | Amygdala | 1 | 2021 | 171 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2018 | 684 | 0.170 |
Why?
| | Disclosure | 1 | 2020 | 100 | 0.160 |
Why?
| | Gray Matter | 2 | 2016 | 67 | 0.160 |
Why?
| | Fear | 1 | 2021 | 292 | 0.160 |
Why?
| | Visual Analog Scale | 1 | 2018 | 30 | 0.160 |
Why?
| | Behavior, Animal | 1 | 2021 | 459 | 0.150 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 63 | 0.140 |
Why?
| | Young Adult | 7 | 2021 | 10444 | 0.140 |
Why?
| | Attitude to Health | 1 | 2020 | 398 | 0.130 |
Why?
| | Proprioception | 1 | 2016 | 19 | 0.130 |
Why?
| | Sensation Disorders | 1 | 2016 | 31 | 0.130 |
Why?
| | Multimodal Imaging | 1 | 2016 | 89 | 0.130 |
Why?
| | Touch Perception | 1 | 2016 | 9 | 0.130 |
Why?
| | Central Nervous System Sensitization | 1 | 2016 | 3 | 0.130 |
Why?
| | Male | 12 | 2021 | 55396 | 0.130 |
Why?
| | Ion Channels | 1 | 2016 | 121 | 0.130 |
Why?
| | Receptors, Opioid, mu | 1 | 2016 | 52 | 0.130 |
Why?
| | Gene Silencing | 1 | 2016 | 171 | 0.130 |
Why?
| | Cognitive Reserve | 1 | 2015 | 14 | 0.120 |
Why?
| | Pain Management | 2 | 2021 | 285 | 0.120 |
Why?
| | Zygapophyseal Joint | 1 | 2015 | 7 | 0.120 |
Why?
| | Rest | 1 | 2015 | 103 | 0.120 |
Why?
| | Imatinib Mesylate | 1 | 2014 | 63 | 0.110 |
Why?
| | Qualitative Research | 1 | 2018 | 919 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 249 | 0.110 |
Why?
| | Spine | 1 | 2015 | 136 | 0.110 |
Why?
| | Yoga | 1 | 2013 | 28 | 0.110 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2012 | 9 | 0.100 |
Why?
| | Skin | 2 | 2014 | 653 | 0.100 |
Why?
| | Neurons, Afferent | 1 | 2012 | 85 | 0.100 |
Why?
| | Hyperalgesia | 1 | 2012 | 107 | 0.100 |
Why?
| | Cognition Disorders | 1 | 2016 | 476 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2020 | 3003 | 0.100 |
Why?
| | Dopamine | 1 | 2013 | 235 | 0.090 |
Why?
| | Biomarkers | 1 | 2021 | 3397 | 0.090 |
Why?
| | Neuronal Plasticity | 1 | 2012 | 207 | 0.090 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 4595 | 0.090 |
Why?
| | Naloxone | 2 | 2021 | 96 | 0.070 |
Why?
| | Models, Neurological | 2 | 2021 | 212 | 0.070 |
Why?
| | Physical Stimulation | 2 | 2016 | 76 | 0.060 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 926 | 0.050 |
Why?
| | Oxygen | 2 | 2018 | 851 | 0.050 |
Why?
| | Cholecystokinin | 1 | 2021 | 15 | 0.050 |
Why?
| | Animals | 3 | 2021 | 31565 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 98 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2015 | 9049 | 0.050 |
Why?
| | Signal Transduction | 1 | 2014 | 4501 | 0.050 |
Why?
| | Aversive Agents | 1 | 2021 | 2 | 0.050 |
Why?
| | Facial Pain | 1 | 2021 | 11 | 0.050 |
Why?
| | Capsaicin | 1 | 2021 | 25 | 0.050 |
Why?
| | Video Recording | 1 | 2021 | 141 | 0.050 |
Why?
| | Photic Stimulation | 1 | 2021 | 203 | 0.040 |
Why?
| | Optogenetics | 1 | 2021 | 95 | 0.040 |
Why?
| | Visual Perception | 1 | 2021 | 140 | 0.040 |
Why?
| | Aged | 2 | 2016 | 18969 | 0.040 |
Why?
| | Adolescent | 4 | 2021 | 17800 | 0.040 |
Why?
| | Genomics | 1 | 2023 | 631 | 0.040 |
Why?
| | Taste | 1 | 2021 | 208 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2018 | 156 | 0.030 |
Why?
| | Flumazenil | 1 | 2016 | 6 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1176 | 0.030 |
Why?
| | Body Water | 1 | 2016 | 19 | 0.030 |
Why?
| | Vibration | 1 | 2016 | 58 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2016 | 114 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1690 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 1947 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2016 | 82 | 0.030 |
Why?
| | Vulvodynia | 1 | 2016 | 2 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2016 | 158 | 0.030 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2016 | 16 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 1791 | 0.030 |
Why?
| | Irritable Bowel Syndrome | 1 | 2016 | 29 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 147 | 0.030 |
Why?
| | Mechanotransduction, Cellular | 1 | 2016 | 97 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1360 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2016 | 260 | 0.030 |
Why?
| | Postmenopause | 1 | 2016 | 301 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 474 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2016 | 135 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 590 | 0.030 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2013 | 5 | 0.030 |
Why?
| | Sulpiride | 1 | 2013 | 5 | 0.030 |
Why?
| | Thermosensing | 1 | 2013 | 10 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 722 | 0.030 |
Why?
| | Phenylalanine | 1 | 2013 | 57 | 0.030 |
Why?
| | Rats | 1 | 2021 | 4913 | 0.030 |
Why?
| | Presynaptic Terminals | 1 | 2013 | 55 | 0.030 |
Why?
| | Mice | 2 | 2021 | 14843 | 0.030 |
Why?
| | Receptors, Dopamine D2 | 1 | 2013 | 86 | 0.030 |
Why?
| | Tyrosine | 1 | 2013 | 210 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4680 | 0.020 |
Why?
| | White Matter | 1 | 2013 | 105 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 926 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 6077 | 0.020 |
Why?
| | Attention | 1 | 2013 | 394 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2550 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 2784 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2537 | 0.020 |
Why?
| | Anxiety | 1 | 2013 | 843 | 0.020 |
Why?
| | Child | 1 | 2016 | 18401 | 0.010 |
Why?
|
|
Ceko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|